Exploration of novel preoperative treatments for pancreatic cancer based on the resectability classification

Exploration of novel preoperative treatments for pancreatic cancer based on the resectability classification - Novel preoperative treatments for pancreatic cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041189

Enrollment

200

Registered

2020-07-22

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic adenocarcinoma Tolerable for surgery Maintaining normal bone marrow, liver, and renal functions Maintaining oral intake Written informed consent

Exclusion criteria

Exclusion criteria: Refusal of participation Interstitial pneumonia Other types of pancreatic cancer Intolerable for surgery Presence of treatments prior to the enrollment Double cancer

Design outcomes

Primary

Measure	Time frame
Resection rate, R0 resection rate	—

Secondary

Measure	Time frame
Overall survival rate, Recurrence-free survival rate, Safety and efficacy of preoperative treatments	—

Countries

Japan

Contacts

Public ContactTaku Aoki

Dokkyo Medical University Second Department of Surgery

aoki-2su@dokkyomed.ac.jp0282872158

Outcome results